tiprankstipranks
Advertisement
Advertisement

PMVP Stock Latest News

PMVP Earnings this Week: How Will it Perform?
Pre-EarningsPMVP Earnings this Week: How Will it Perform?
3d ago
PMVP
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
PremiumThe Fly
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
16d ago
KLRA
PMVP
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
PremiumThe Fly
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
25d ago
PMVP
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
PremiumCompany Announcements
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
2M ago
PMVP
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
PremiumThe Fly
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
2M ago
PMVP
PMV Pharmaceuticals sees cash runway to end of 2Q27
PremiumThe FlyPMV Pharmaceuticals sees cash runway to end of 2Q27
2M ago
PMVP
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
2M ago
PMVP
PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
Premium
The Fly
PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
2M ago
PMVP
PMV Pharmaceuticals Reports Increased Quarterly Loss
PremiumCompany Announcements
PMV Pharmaceuticals Reports Increased Quarterly Loss
6M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
PremiumRatings
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
6M ago
PMVP
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
PremiumRatings
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
6M ago
PMVP
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
PremiumThe Fly
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
6M ago
PMVP
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
PremiumCompany AnnouncementsPMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
6M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
Premium
Ratings
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
6M ago
PMVP
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
Premium
The Fly
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
7M ago
PMVP
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
PremiumRatings
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
8M ago
PMVP
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
PremiumCompany Announcements
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
8M ago
8K
PMVP
PMV Pharmaceuticals announces interim data from Phase 2 portion of PYNNACLE
PremiumThe Fly
PMV Pharmaceuticals announces interim data from Phase 2 portion of PYNNACLE
8M ago
PMVP
PMV Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
PMV Pharmaceuticals Reports Q2 2025 Financial Results
9M ago
PMVP
PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
PremiumThe FlyPMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
9M ago
PMVP
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
Premium
Company Announcements
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
11M ago
8K
PMVP
PMV Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
PMV Pharmaceuticals Reports Q1 2025 Financial Results
12M ago
PMVP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >